Sanara Medtech Inc. (SMTI) - Form 8-K Summary
Business Context and Reporting Period
Sanara Medtech Inc., a Texas-based company trading on the Nasdaq Capital Market under the symbol SMTI, filed this Current Report on Form 8-K on January 23, 2026. The filing serves to announce preliminary financial results for the fourth quarter and the full year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report explicitly states that the preliminary financial results are contained within a press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No material changes versus prior periods are quantified in this filing. The document acts solely as a notification of the release of preliminary results for Q4 and full-year 2025.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information, including the referenced press release, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference in other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed within the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 23, 2026) for the actual preliminary financial figures for Q4 and full-year 2025.
- Verify the company's liquidity position and cash burn rate in the referenced press release, as these are not listed in the 8-K summary.
- Confirm whether the preliminary results include any restatements or adjustments to prior period data.
- Check for any forward-looking statements or updated guidance included in the full press release text.